Samir Khleif
Corporate Officer/Principal en INTELLIGENT MEDICINE ACQUISITION CORP. .
Fortuna: 38 $ al 31/03/2024
Perfil
Samir N.
Khleif is the founder of Georgiamune, Inc. He currently holds multiple positions including Chief Executive Officer at King Hussein Cancer Center, Director at Augusta University, Director at Georgia Cancer Center, Venture Advisor at Israel Biotech Fund, and Advisor at Intelligent Medicine Acquisition Corp.
Previously, he served as an Independent Director at Advaxis, Inc., Director at Ayala Pharmaceuticals, Inc., and Chief-Cancer Vaccine Section at National Cancer Institute.
Khleif received his undergraduate degree from Augusta University and his graduate degree from the University of Jordan Medical School in 1986.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
12/12/2022 | 59 ( 0.00% ) | 38 $ | 31/03/2024 |
Cargos activos de Samir Khleif
Empresas | Cargo | Inicio |
---|---|---|
INTELLIGENT MEDICINE ACQUISITION CORP. | Corporate Officer/Principal | - |
Augusta University | Director/Board Member | - |
Georgia Cancer Center | Director/Board Member | - |
Georgiamune, Inc.
Georgiamune, Inc. BiotechnologyHealth Technology Georgiamune, Inc. is a clinical stage biotechnology company that focuses on reprogramming immune signaling pathways to redirect the immune system to fight diseases. The company is based in Silver Spring, MD. The company has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. Georgiamune's lead program, Gim-122, is a first-in-class, dual-functioning monoclonal antibody designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases. The company was founded by Samir N. Khleif, a world-renowned medical oncologist and researcher in the field of immunology and cancer, based on discoveries in his lab on novel mechanisms to modulate immune response. Samir N. Khleif has been the CEO since incorporation. | Chief Executive Officer | - |
King Hussein Cancer Center | Chief Executive Officer | - |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - |
Antiguos cargos conocidos de Samir Khleif.
Empresas | Cargo | Fin |
---|---|---|
AYALA PHARMACEUTICALS, INC. | Director/Board Member | 19/10/2023 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
AYALA PHARMACEUTICALS, INC. | Director/Board Member | - |
Formación de Samir Khleif.
Augusta University | Undergraduate Degree |
University of Jordan Medical School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AYALA PHARMACEUTICALS, INC. | Commercial Services |
Empresas privadas | 7 |
---|---|
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
King Hussein Cancer Center | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Georgia Cancer Center | |
Georgiamune, Inc.
Georgiamune, Inc. BiotechnologyHealth Technology Georgiamune, Inc. is a clinical stage biotechnology company that focuses on reprogramming immune signaling pathways to redirect the immune system to fight diseases. The company is based in Silver Spring, MD. The company has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. Georgiamune's lead program, Gim-122, is a first-in-class, dual-functioning monoclonal antibody designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases. The company was founded by Samir N. Khleif, a world-renowned medical oncologist and researcher in the field of immunology and cancer, based on discoveries in his lab on novel mechanisms to modulate immune response. Samir N. Khleif has been the CEO since incorporation. | Health Technology |
Intelligent Medicine Acquisition Corp.
Intelligent Medicine Acquisition Corp. Electrical ProductsProducer Manufacturing Intelligent Medicine Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Bethesda, MD. | Producer Manufacturing |
- Bolsa de valores
- Insiders
- Samir Khleif